مورد إلكتروني

PSA response to lenalidomide therapy in a pre-treated patient with metastatic prostate cancer refractory to hormones and chemotherapy: a case report

التفاصيل البيبلوغرافية
العنوان: PSA response to lenalidomide therapy in a pre-treated patient with metastatic prostate cancer refractory to hormones and chemotherapy: a case report
بيانات النشر: S. Karger AG, Basel 2012-04-18
تفاصيل مُضافة: Universidad de Alicante. Departamento de Biotecnología
Gasent Blesa, Joan Manel
Peris Godoy, Miguel
Fonfría Esparcia, María
Blasco Mollá, Sara
Mancheño Magán, Balbino
Sempere Ortells, José Miguel
Sánchez, José Luis
نوع الوثيقة: Electronic Resource
مستخلص: Hormone-resistant prostate cancer (HRPC) occurs when prostate cancer is no longer responsive to hormone therapy. Treatment options are limited, and there is a clear necessity for therapies that improve outcome. Preclinical and clinical evidence supports the role of the immunomodulatory agent lenalidomide in HRPC. In this paper, we report that lenalidomide showed antitumoral activity in a patient with HRPC and bone metastases pre-treated with chemotherapy, decreased the PSA level and improved the patient’s health status for the first 5 months. It is important to emphasize that it was not associated with hematologic toxicity.
مصطلحات الفهرس: Hormone-resistant prostate cancer, Prostate serum antigen, Lenalidomide, info:eu-repo/semantics/article
URL: http://hdl.handle.net/10045/34301
http://dx.doi.org/10.1159/000336481
الإتاحة: Open access content. Open access content
info:eu-repo/semantics/openAccess
© 2012 S. Karger AG, Basel. This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online version of the article only. Distribution for non-commercial purposes only.
أرقام أخرى: ESALI oai:rua.ua.es:10045/34301
Case Reports in Oncology. 2012, 5: 181-186. doi:10.1159/000336481
1662-6575
10.1159/000336481
1364507811
المصدر المساهم: UNIV DE ALICANTE
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.on1364507811
قاعدة البيانات: OAIster